Psoralea Seed

Psoralea seed (Psoralea corylifolia) contains over 100 bioactive compounds—most notably bakuchiol, psoralen, psoralidin, and isopsoralen—that modulate apoptosis via caspase-3/p53/Bax pathways, stimulate melanogenesis, and exhibit clinically validated anti-aging effects comparable to retinol (PMID 24471735). A comprehensive 2019 ethnopharmacological review confirmed the seed's broad pharmacological profile spanning antioxidant, osteoblastic, immunomodulatory, anticancer, and neuroprotective activities across in vitro and animal models (PMID 30521980).

Category: Seed Evidence: 8/10 Tier: Tier 1 (authoritative)

Origin & History

Psoralea Seed (*Psoralea corylifolia*) is derived from the seeds of a herbaceous plant native to India and China. Revered in traditional medicine, it is valued for its potent bioactive compounds. This ingredient offers significant potential for supporting skin vitality, bone strength, and overall cellular rejuvenation in functional nutrition.

Historical & Cultural Context

Psoralea seed, known as "Bakuchi" in Ayurveda and "Bu Gu Zhi" in Traditional Chinese Medicine (TCM), has been revered for millennia. It was traditionally used for skin rejuvenation, pigment restoration, bone strengthening, hormonal regulation, and reproductive support. This ancient botanical continues to be valued for enhancing vitality and overall wellness.

Health Benefits

- Enhances skin vitality and pigment restoration through compounds like psoralen and isopsoralen.
- Strengthens bone density by supporting calcium and phosphorus metabolism.
- Modulates hormonal balance, contributing to overall endocrine system wellness.
- Boosts immune resilience by providing antioxidant and anti-inflammatory support.
- Supports cognitive clarity through neuroprotective and anti-inflammatory actions.
- Aids digestive wellness by contributing dietary fiber and beneficial phytochemicals.
- Promotes cellular rejuvenation by reducing oxidative stress with flavonoids and coumarins.

How It Works

Psoralen, the principal furanocoumarin in Psoralea seed, induces apoptosis through upregulation of caspase-3, p53, and Bax while downregulating the anti-apoptotic protein Bcl-2, and simultaneously arrests the cell cycle at G0/G1 and G2/M phases by inhibiting Wnt/β-catenin signaling (PMID 26916913). Bakuchiol triggers S-phase cell cycle arrest via the p38-MAPK/ROS/p53 axis and suppresses proliferation through JNK pathway activation; gene expression profiling shows it modulates retinoid-responsive genes (including type I, III, and IV collagen upregulation and MMP-12 downregulation) without binding retinoid receptors directly (PMID 24471735; PMID 36748816). Psoralidin exerts potent anti-inflammatory effects by inhibiting TLR2-mediated NF-κB and MAPK signaling, reducing pro-inflammatory cytokines TNF-α, IL-6, and IL-1β in acute lung injury models (PMID 40516289). Additionally, isopsoralen and other furanocoumarins stimulate melanocyte proliferation and tyrosinase activity, underpinning the seed's historical use for vitiligo and phototherapy-assisted repigmentation (PMID 30521980).

Scientific Research

A gene-expression profiling study published in the International Journal of Cosmetic Science demonstrated that bakuchiol from Psoralea corylifolia exhibits retinol-like anti-aging activity, significantly improving wrinkles, pigmentation, and skin elasticity in a 12-week clinical trial (Chaudhuri RK, 2014; PMID 24471735). A clinical evaluation in the Journal of Drugs in Dermatology confirmed that a bakuchiol-based moisturizer improved fine lines, firmness, and overall photodamage in sensitive-skin subjects with minimal irritation (Draelos ZD, 2020; PMID 33346506). Chopra B (2023) published a comprehensive review in Anticancer Agents in Medicinal Chemistry detailing bakuchiol's anticancer mechanisms, including induction of apoptosis and cell cycle arrest in multiple cancer cell lines (PMID 36717993). A 2025 study in Phytomedicine revealed that psoralidin, another key Psoralea constituent, protects against sepsis-induced acute lung injury through TLR2-mediated anti-inflammatory signaling in murine models (Jiang S; PMID 40516289).

Clinical Summary

Clinical evidence remains limited to small studies showing psoralen at 0.4 mg/kg inhibited cell proliferation and normalized NGF and Sema3A expression in psoriasis and atopic dermatitis patients. Most research consists of preclinical in vitro and animal studies demonstrating antioxidant, anti-inflammatory, and cytotoxic effects. No large-scale randomized controlled trials have been conducted to establish definitive clinical efficacy. Human clinical trials are needed to determine optimal dosing protocols and therapeutic endpoints.

Nutritional Profile

- Phytochemicals: Psoralen, Isopsoralen, Flavonoids (Bavachin, Corylin), Coumarins, Terpenoids, Phytosterols.
- Minerals: Calcium, Magnesium, Phosphorus.
- Dietary Fiber.

Preparation & Dosage

- Powdered Extract: Consume 500–1000 mg daily, ideally under professional supervision.
- Herbal Tea: Brew 1–2 grams of dried seeds in hot water for 10–15 minutes, up to twice daily.

Synergy & Pairings

Role: Adaptogenic base
Intention: Cognition & Focus | Hormonal Balance
Primary Pairings: - Ashwagandha (Withania somnifera)
- Turmeric (Curcuma longa)
- Licorice Root (Glycyrrhiza glabra)
- Ginkgo Biloba (Ginkgo biloba)

Safety & Interactions

Psoralea seed furanocoumarins (psoralen, isopsoralen) are potent photosensitizers and must be used with strict UV avoidance; concurrent phototherapy should only occur under medical supervision due to risk of phototoxic burns and increased skin cancer susceptibility (PMID 30521980). In vitro studies indicate psoralen and bakuchiol inhibit CYP1A2 and CYP2C9 isoenzymes, creating potential interactions with warfarin, theophylline, and other CYP-metabolized drugs; dose adjustments may be necessary (PMID 26916913). Hepatotoxicity has been reported in animal models at high doses, particularly with prolonged use of concentrated Psoralea extracts, so liver function monitoring is recommended during supplementation (PMID 30521980). Psoralea seed is contraindicated during pregnancy due to its estrogenic activity and potential teratogenicity, and should be used cautiously in individuals with hepatic impairment or autoimmune conditions (PMID 36748816).